About UCL
UCL is a Healthcare company based in Kikuyu (Kenya) founded in 1996, and was acquired by Strides Arcolab in February 2016. Generic pharmaceutical products are manufactured across multiple African countries. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified.
Company details
Universal Corporation was established in 1996 and is based in Kikuyu, Kenya. Operations span the pharmaceutical sector, with manufacturing focused on generic drugs. Presence is maintained in Malawi, Mozambique, Zambia, Burundi, Rwanda, Congo, DRC, Sierra Leone, Somalia, Angola, Tanzania, and Uganda. Products encompass antimalarials, antivirals, antibiotics, analgesics, central nervous system medications, and cardiovascular treatments.
- Headquarters Kikuyu, Kenya
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website ucl.co.ke
- Social LinkedIn X Facebook
- Acquired by Strides Arcolab (Feb 2016)
- Investors
- Acquired byStrides Arcolab
(Feb 2016)
Investors in UCL
UCL has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Strides Arcolab.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Manufacturer of IP-led niche finished dosage formulations and soft gelatin capsules | 1990 | stridesarco.com | Bengaluru, India |
Investor details for UCL
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of UCL
8 people are tracked at UCL (4 in leadership, 4 in team).
| Name | Role | Group |
|---|---|---|
Penti Keskitallo | Technical Director | Leadership |
Perviz Dhanani | Managing Director | Leadership |
Amit Himmatsinghka | Chief Financial Officer | Leadership |
Saurav Sarkar | Assistant General Manager | Leadership |
Nancy Kagure | Senior Quality Control Analyst. | Team |
Nickson Onyango | Assistant Manager | Team |
Yogesh Shukla | Assistant Manager | Team |
Kiprono Denis | Quality Assurance Supervisor | Team |
Complete people profiles for UCL
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of UCL
2 dated milestones of UCL across 20 years, from founding to its latest funding, stage changes and deals.
- Founded UCL is founded.
- Exit Acquired by Strides Arcolab.
Web traffic of UCL
The website of UCL (ucl.co.ke) receives about 2.1K visits a month.
- Monthly visits2.1K
▲ 159.3% vs previous month
Websites whose visitors overlap most with UCL. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
catalog.md | catalog.md | 100% | #5,271,396 | – | |
keeler.co.uk | keeler.co.uk | 39% | #1,243,233 | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about UCL
UCL was founded in 1996.
UCL is headquartered in Kikuyu, Kenya. It is registered at Kikuyu, Kiambu, Kenya.
Universal Corporation was established in 1996 and is based in Kikuyu, Kenya. Operations span the pharmaceutical sector, with manufacturing focused on generic drugs. Presence is maintained in Malawi, Mozambique, Zambia, Burundi, Rwanda, Congo, DRC, Sierra Leone, Somalia, Angola, Tanzania, and Uganda. Products encompass antimalarials, antivirals, antibiotics, analgesics, central nervous system medications, and cardiovascular treatments.
UCL has 1 investor. Key investors include Strides Arcolab.
Yes. UCL was acquired by Strides Arcolab in February 2016.